Αποτελέσματα αναζήτησης - Masahiko Yanagita
- Εμφανίζονται 1 - 4 Αποτελέσματα από 4
-
1
A Prospective Evaluation of Circulating Tumor Cells and Cell-Free DNA in <i>EGFR</i>-Mutant Non–Small Cell Lung Cancer Patients Treated with Erlotinib on a Phase II Trial από Masahiko Yanagita, Amanda J. Redig, Cloud P. Paweletz, Suzanne E. Dahlberg, Allison O’Connell, Nora Feeney, Myriam Taibi, David Boucher, Geoffrey R. Oxnard, Bruce E. Johnson, Daniel B. Costa, David M. Jackman, Pasi A. Jänne
Έκδοση 2016Artigo -
2
Reactivation of ERK Signaling Causes Resistance to EGFR Kinase Inhibitors από Dalia Ercan, Chunxiao Xu, Masahiko Yanagita, Calixte S. Monast, Christine A. Pratilas, Joan Montero, Mohit Butaney, Takeshi Shimamura, Lynette M. Sholl, Elena Ivanova, Madhavi Tadi, Andrew M. Rogers, Claire E. Repellin, Marzia Capelletti, Ophélia Maertens, Eva M. Goetz, Anthony Letai, Levi A. Garraway, Matthew J. Lazzara, Neal Rosen, Nathanael S. Gray, Kwok‐Kin Wong, Pasi A. Jänne
Έκδοση 2012Artigo -
3
A Novel ALK Secondary Mutation and EGFR Signaling Cause Resistance to ALK Kinase Inhibitors από Takaaki Sasaki, Jussi Koivunen, Atsuko Ogino, Masahiko Yanagita, Sarah Nikiforow, Wei Zheng, Christopher S. Lathan, Judith Marcoux, Jinyan Du, Katsuhiro Okuda, Marzia Capelletti, Takeshi Shimamura, Dalia Ercan, Magda Stumpfova, Yun Xiao, Stanislawa Weremowicz, Mohit Butaney, Stéphanie Héon, Keith D. Wilner, James G. Christensen, Michel J. Eck, Kwok‐Kin Wong, Neal I. Lindeman, Nathanael S. Gray, Scott J. Rodig, Pasi A. Jänne
Έκδοση 2011Artigo -
4
A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response από Chen Zhao, Katherine A. Cheng, Zandra E. Walton, Yuchuan Wang, Hiromichi Ebi, Takeshi Shimamura, Yan Liu, Tanya Tupper, Jing Ouyang, Jie Li, Peng Gao, Michele Sue‐Ann Woo, Chunxiao Xu, Masahiko Yanagita, Abigail Altabef, Shumei Wang, Charles Lee, Yuji Nakada, Christopher G. Peña, Yanping Sun, Yoko Franchetti, Catherine Yao, Amy Saur, Michael D. Cameron, Mizuki Nishino, D. Neil Hayes, Matthew D. Wilkerson, Patrick J. Roberts, Carrie B. Lee, Nabeel Bardeesy, Mohit Butaney, Lucian R. Chirieac, Daniel B. Costa, David M. Jackman, Norman E. Sharpless, Diego H. Castrillón, George D. Demetri, Pasi A. Jänne, Pier Paolo Pandolfi, Lewis C. Cantley, Andrew L. Kung, Jeffrey A. Engelman, Kwok‐Kin Wong
Έκδοση 2012Artigo
Εργαλεία αναζήτησης:
Σχετικά θέματα
Biology
Cancer
Cancer research
Epidermal growth factor receptor
Internal medicine
Lung cancer
Medicine
Oncology
Biochemistry
Erlotinib
Gefitinib
Gene
Receptor
T790M
ALK inhibitor
Anaplastic lymphoma kinase
Bioinformatics
Cell biology
Circulating tumor cell
Clinical trial
Colorectal cancer
Crizotinib
Docetaxel
EGFR inhibitors
Genetic testing
Genetically engineered
Genetics
Genotype
Genotyping
KRAS